PMID- 21217921 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20110714 LR - 20211020 IS - 2092-7363 (Electronic) IS - 2092-7355 (Print) IS - 2092-7355 (Linking) VI - 3 IP - 1 DP - 2011 Jan TI - Biomarkers predicting isocyanate-induced asthma. PG - 21-6 LID - 10.4168/aair.2011.3.1.21 [doi] AB - THREE DIISOCYANATES CAN CAUSE OCCUPATIONAL ASTHMA (OA): toluene diisocyanate (TDI), 4,4 diphenylmethane diisocyanate (MDI), and 1,6-hexamethylene diisocyanate (HDI). We analyzed potential biomarkers of isocyanate-induced OA, based on investigated immunologic, genetic, neurogenic, and protein markers, because there is no serological testing method. The prevalence of serum IgG to cytokeratin (CK)18 and CK19 in TDI-OA was significantly higher than in controls, although the prevalence of these antibodies was too low for them to be used as biomarkers. Another candidate biomarker was serum IgG to tissue transglutaminase (tTG), because the prevalence of serum specific IgG to tTG was significantly higher in patients with TDI-OA than in controls. The human leukocyte antigen (HLA) DRB1*1501-DQB1*0602-DPB1*0501 haplotype may be used as a genetic marker for TDI-OA in Koreans via enhanced specific IgE sensitization in exposed subjects. The genetic polymorphisms of catenin alpha 3, alpha-T catenin (CTNNA3) were significantly associated with TDI-OA. Additionally, examining the neurokinin 2 receptor (NK2R) 7853G>A and 11424 G>A polymorphisms, the NK2R 7853GG genotype had higher serum vascular endothelial growth factor (VEGF) levels than the GA or AA genotypes among Korean workers exposed to TDI. To identify new serologic markers using a proteomic approach, differentially expressed proteins between subjects with MDI-OA and asymptomatic exposed controls in a Korean population showed that the optimal serum cutoff levels were 69.8 ng/mL for ferritin and 2.5 microg/mL for transferrin. When these two parameters were combined, the sensitivity was 71.4% and the specificity was 85.7%. The serum cytokine matrix metalloproteinase-9 (MMP-9) level is a useful biomarker for identifying cases of TDI-OA among exposed workers. Despite these possible biomarkers, more effort should be focused on developing early diagnostic biomarkers using a comprehensive approach based on the pathogenic mechanisms of isocyanate-induced OA. FAU - Palikhe, Nami Shrestha AU - Palikhe NS AD - Department of Allergy & Rheumatology, Ajou University School of Medicine, Suwon, Korea. FAU - Kim, Joo-Hee AU - Kim JH FAU - Park, Hae-Sim AU - Park HS LA - eng PT - Journal Article DEP - 20100729 PL - Korea (South) TA - Allergy Asthma Immunol Res JT - Allergy, asthma & immunology research JID - 101518382 PMC - PMC3005314 OTO - NOTNLM OT - 4,4-diphenylmethane diisocyanate OT - Isocyanate OT - biomarkers OT - occupational asthma OT - toluene diisocyanate COIS- There are no financial or other issues that might lead to conflict of interest. EDAT- 2011/01/11 06:00 MHDA- 2011/01/11 06:01 PMCR- 2011/01/01 CRDT- 2011/01/11 06:00 PHST- 2010/05/18 00:00 [received] PHST- 2010/06/01 00:00 [accepted] PHST- 2011/01/11 06:00 [entrez] PHST- 2011/01/11 06:00 [pubmed] PHST- 2011/01/11 06:01 [medline] PHST- 2011/01/01 00:00 [pmc-release] AID - 10.4168/aair.2011.3.1.21 [doi] PST - ppublish SO - Allergy Asthma Immunol Res. 2011 Jan;3(1):21-6. doi: 10.4168/aair.2011.3.1.21. Epub 2010 Jul 29.